Clinical Trials Verified stories whose regulatory record supports clinical-trial access. Eligibility and enrollment are never guaranteed.
Filter clinical trials Filters Results 97 verified trial-access stories match your filters.
Important: Eligibility and enrollment are not guaranteed, and listing here is not a treatment recommendation. Talk to your care team.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Bladder Cancer
Trial identifier NCT07795255
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Bladder (Urothelial, Transitional Cell) Cancer, Hematuria who meet the study-specific registry eligibility criteria.
Last reviewed 2026-09-01 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-09-01 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Lung Cancer
Trial identifier NCT04538664
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Carcinoma, Non-Small-Cell Lung who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-31 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-31 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Ovarian Cancer
Trial identifier NCT07776691
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer, Fallopian Tube Cancer who meet the study-specific registry eligibility criteria; sex eligibility: female.
Last reviewed 2026-08-31 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-31 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Leukemia
Trial identifier NCT06852222
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Leukemia, Myeloid, Acute who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-29 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-29 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Multiple Myeloma
Trial identifier NCT07518186
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Multiple Myeloma who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-29 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-29 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Ovarian Cancer
Trial identifier NCT01081262
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Borderline Ovarian Mucinous Tumor, Ovarian Mucinous Cystadenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma who meet the study-specific registry eligibility criteria; sex eligibility: female.
Last reviewed 2026-08-29 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-29 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Bladder Cancer
Trial identifier NCT06319820
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Non-Muscle Invasive Bladder Neoplasms who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-28 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-28 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Bladder Cancer
Trial identifier NCT04658862
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Urinary Bladder Neoplasms who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-28 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-28 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Leukemia
Trial identifier NCT07211958
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 12 Years and older with Acute Myeloid Leukemias who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-28 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-28 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
⚕ Regulatory status: Investigational ▣ Evidence stage: Later-Stage Human
Cancer type Breast Cancer
Trial identifier NCT00070564
Trial phase Phase 3 View trial details
Study design Other / not applicable
Population Participants age 18 Years and older with Breast Cancer who meet the study-specific registry eligibility criteria.
Last reviewed 2026-08-28 Regulatory status by jurisdiction Unspecified jurisdiction
Status Investigational
Last verified 2026-08-28 This record has no structured cancer-type scope on file yet — editorial review recommended before treating it as applicable to a specific cancer type.
Primary evidence supporting this story Eligibility varies — review trial criteria.
CancerDiscoveries summarizes verified records in its database. Absence of a listing here does not establish that a treatment lacks regulatory authorization or access.